Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EUropean Pharmacogenetics of AntiCoagulation Therapy trial
2009-016993-34Phase 4Completed
- Sponsor
- Akademiska sjukhuset
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of warfarin in venous thromboembolism (VTE) and Atrial fibrillation (AFib) (2 arms), sponsored by Akademiska sjukhuset. Primary endpoint: Time in therapeutic INR range. Started Jul 2010; status: completed.
02
Drugs
warfarin
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2009-016993-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016993-34.